TRIM56 impairs HBV infection and replication by inhibiting HBV core promoter activity.
Tian X, Dong H, Lai X, Ou G, Cao J, Shi J, Xiang C, Wang L, Zhang X, Zhang K, Song J, Deng J, Deng H, Lu S, Zhuang H, Li T, Xiang K.
Tian X, et al. Among authors: shi j.
Antiviral Res. 2022 Nov;207:105406. doi: 10.1016/j.antiviral.2022.105406. Epub 2022 Sep 7.
Antiviral Res. 2022.
PMID: 36084850